Lineage Cell Therapeutics, Inc. (LCTX) Revenue 2016–2025
Lineage Cell Therapeutics, Inc. (LCTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$14.6MFY2025 · since FY2016: $5.9M → $14.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.6M | +53.2% |
| FY2024 | $9.5M | +6.2% |
| FY2023 | $8.9M | -39.2% |
| FY2022 | $14.7M | +238.7% |
| FY2021 | $4.3M | +137.7% |
| FY2020 | $1.8M | -48.1% |
| FY2019 | $3.5M | -29.5% |
| FY2018 | $5.0M | +44.2% |
| FY2017 | $3.5M | -41.6% |
| FY2016 | $5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice